HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structure-based discovery of Tipranavir disodium (PNU-140690E): a potent, orally bioavailable, nonpeptidic HIV protease inhibitor.

Abstract
Efforts to develop therapeutically relevant HIV protease inhibitors as medicinal agents in confronting the AIDS crisis have been aided by the wealth of fundamental information acquired during related drug discovery campaigns against other aspartyl proteases. This knowledge base was brought to full force with the broad screening identification of small, nonpeptidic, inhibitory molecules as templates for chemical elaboration. Significantly, the ability to collect crystallographic data on the inhibitor-enzyme complexes in a rapid fashion afforded the opportunity for a structure-based approach to drug discovery. Iterative cycles of synthesis, biological testing, and structural information gathering followed by prudent design modifications afforded compounds suitable for clinical evaluation. Displaying high enzymatic inhibition (Ki = 8 pM), potent in vitro antiviral cell culture activity (IC90 = 100 nM), and a useful pharmacokinetic profile, PNU-140690E (Tipranavir disodium) has entered into clinical studies. Promising results from these early trials supported further evaluation of this compound in HIV-infected individuals. PNU-140690E is currently under extensive clinical study.
AuthorsS Thaisrivongs, J W Strohbach
JournalBiopolymers (Biopolymers) Vol. 51 Issue 1 Pg. 51-8 ( 1999) ISSN: 0006-3525 [Print] United States
PMID10380352 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Pyridines
  • Pyrones
  • Sulfonamides
  • tipranavir
Topics
  • Administration, Oral
  • Anti-HIV Agents (chemistry, pharmacokinetics, therapeutic use)
  • Biological Availability
  • Drug Design
  • HIV Infections (drug therapy)
  • HIV Protease Inhibitors (chemistry, pharmacokinetics, therapeutic use)
  • Humans
  • Models, Molecular
  • Pyridines (chemistry, pharmacokinetics, therapeutic use)
  • Pyrones (chemistry, pharmacokinetics, therapeutic use)
  • Structure-Activity Relationship
  • Sulfonamides

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: